Home » Patent Reform Law Differences to Remain Until After Debt Talks
Patent Reform Law Differences to Remain Until After Debt Talks
The biopharma industry must wait a few more months to see how differences between House- and Senate-passed versions of a patent reform bill are ironed out, Capitol Hill staffers say.
Generic Line
Generic Line
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May